Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current developments in nucleoside/nucleotide analogues for hepatitis B.

Expert review of gastroenterology & hepatology - 1 Aug 2014

Lo Angeline Oi-Shan, Wong Grace Lai-Hung

Abstract excerpt

There had been remarkable development in nucleos(t)ide analogues (NAs) and evolution in treatment strategies in last 15 years. Currently, there are five NAs available for chronic hepatitis B treatment, namely lamivudine, telbivudine and entecavir (nucleoside analogues), adefovir dipivoxil and tenofovir disoproxil fumarate (nucleotide analogues). The advantages of relatively infrequent side effects and easy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Design
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Nucleosides

Share to Nucleotides

Source

Identifiers

PMID: 24787673
DOI: 10.1586/17474124.2014.909724

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current developments in nucleoside/nucleotide analogues for hepatitis B.PMID 24787673Read ↗

Chronic hepatitis B therapy: available drugs and treatment guidelines.Semantic proximity Read ↗

[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].Semantic proximity Read ↗

Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sitesSemantic proximity Read ↗

Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapySemantic proximity Read ↗

Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus InfectionsSemantic proximity Read ↗

Update on hepatitis B virus infection.Semantic proximity Read ↗

Hepatitis B: treatment choice and monitoring for response and resistance.Semantic proximity Read ↗

Comparative evaluation of long-term monotherapies & combination therapies in patients with chronic hepatitis B: A pilot study.Semantic proximity Read ↗

Real-world evidence for nucleoside/nucleotide analogues in a 5-year multicentre study of antiviral-naive chronic hepatitis B patients in China: 52-week results.Semantic proximity Read ↗

Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments.Semantic proximity Read ↗

Monotherapy versus combination therapy for the treatment of chronic hepatitis B.Semantic proximity Read ↗

Viral resistance in hepatitis B: prevalence and management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.